Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.


  • Presentation
  • Question
  • Answer

Question
A phenotypic variant of FAP called [...] syndrome is associated with extraintestinal manifestations of FAP, which include congenital hypertrophy of the retinal pigment epithelium (CHRPE). CHRPE may be an indication of underlying FAP, but it has no attendant health risks for patients with FAP and does not require ongoing surveillance if detected
Answer
Gardner

Question
A phenotypic variant of FAP called [...] syndrome is associated with extraintestinal manifestations of FAP, which include congenital hypertrophy of the retinal pigment epithelium (CHRPE). CHRPE may be an indication of underlying FAP, but it has no attendant health risks for patients with FAP and does not require ongoing surveillance if detected
Answer
?

Question
A phenotypic variant of FAP called [...] syndrome is associated with extraintestinal manifestations of FAP, which include congenital hypertrophy of the retinal pigment epithelium (CHRPE). CHRPE may be an indication of underlying FAP, but it has no attendant health risks for patients with FAP and does not require ongoing surveillance if detected
Answer
Gardner
If you want to change selection, open original toplevel document below and click on "Move attachment"

Parent (intermediate) annotation

Open it
A phenotypic variant of FAP called Gardner syndrome is associated with extraintestinal manifestations of FAP, which include congenital hypertrophy of the retinal pigment epithelium (CHRPE). CHRPE may be an indication o

Original toplevel document (pdf)

owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2732

Summary

statusnot learnedmeasured difficulty37% [default]last interval [days]               
repetition number in this series0memorised on               scheduled repetition               
scheduled repetition interval               last repetition or drill

Details

No repetitions

Discussion

Do you want to join discussion? Click here to log in or create user.